Home
/
Vivani Medical, Inc.
/
Financials
/
Quarterly
Vivani Medical, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Vivani Medical, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2016
Mar 31, 2016
$1.1K
May 6, 2016
Q3
2015
Sep 30, 2015
$2.23M
Nov 16, 2015
Q2
2015
Jun 30, 2015
$2.66M
Aug 5, 2015
Q1
2016
Mar 31, 2015
$1.7K
May 6, 2016
Q3
2015
Sep 30, 2014
$609.4K
Nov 16, 2015
Q2
2015
Jun 30, 2014
$611.5K
Aug 5, 2015
Q1
2015
Mar 31, 2014
$656.7K
May 15, 2015
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($6.53M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($7.14M)
Aug 13, 2025
Q3
2025
Jun 30, 2025
($7.14M)
Nov 13, 2025
Q1
2025
Mar 31, 2025
($6.30M)
May 13, 2025
Q2
2025
Mar 31, 2025
($6.30M)
Aug 13, 2025
Q3
2025
Mar 31, 2025
($6.30M)
Nov 13, 2025
Q3
2025
Sep 30, 2024
($6.04M)
Nov 13, 2025
Q3
2025
Jun 30, 2024
($5.36M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($5.36M)
Aug 13, 2025
Q3
2025
Mar 31, 2024
($6.04M)
Nov 13, 2025
Q1
2025
Mar 31, 2024
($6.04M)
May 13, 2025
Q2
2025
Mar 31, 2024
($6.04M)
Aug 13, 2025
Q3
2024
Sep 30, 2023
($6.78M)
Nov 13, 2024
Q3
2024
Jun 30, 2023
($6.53M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($6.53M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($6.32M)
May 13, 2024
Q2
2024
Mar 31, 2023
($6.32M)
Aug 13, 2024
Q3
2024
Mar 31, 2023
($6.32M)
Nov 13, 2024
Q3
2023
Sep 30, 2022
$1.42M
Nov 13, 2023
Q2
2023
Jun 30, 2022
($4.10M)
Aug 14, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($6.73M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($7.46M)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($6.56M)
May 13, 2025
Q3
2025
Sep 30, 2024
($6.31M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($5.68M)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($6.23M)
May 13, 2025
Q3
2024
Sep 30, 2023
($7.14M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($7.00M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($6.60M)
May 13, 2024
Q3
2023
Sep 30, 2022
($5.44M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($4.09M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($3.91M)
May 15, 2023
Q3
2022
Sep 30, 2021
($3.49M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($2.30M)
Aug 12, 2022
Q1
2022
Mar 31, 2021
($2.84M)
May 16, 2022
Q3
2021
Sep 30, 2020
($1.60M)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($3.12M)
Aug 13, 2021
Q1
2021
Mar 31, 2020
($8.90M)
May 13, 2021
Q3
2020
Sep 30, 2019
($7.62M)
Nov 12, 2020
Q2
2020
Jun 30, 2019
($8.44M)
Aug 13, 2020